Duality Advisers’s Zimmer Biomet ZBH Stock Holding History

Duality Advisers’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,680	Closed	-$301K	–	772
2023 Q3	$301K	Buy	+2,680	New	+$340K	0.04%	485
2022 Q1	–	Sell	-53,183	Closed	-$6.56M	–	857
2021 Q4	$6.56M	Buy	+53,183	New	+$6.96M	0.71%	13
2021 Q2	–	Sell	-17,910	Closed	-$2.78M	–	751
2021 Q1	$2.78M	Buy	+17,910	New	+$2.77M	0.24%	141
2020 Q4	–	Sell	-2,060	Closed	-$272K	–	761
2020 Q3	$272K	Buy	+2,060	New	+$269K	0.02%	534
2019 Q4	–	Sell	-1,854	Closed	-$247K	–	451
2019 Q3	$247K	Sell	1,854 -13,555	-88%	-$1.75M	0.01%	322
2019 Q2	$1.76M	Buy	+15,409	New	+$1.8M	0.15%	154
2019 Q1	–	Sell	-115,432	Closed	-$11.6M	–	287
2018 Q4	$11.6M	Buy	+115,432	New	+$13M	0.68%	30

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Duality Advisers's ZBH Position: Q4 2023 in Review

Duality Advisers sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 2,680 shares — an estimated $301K sold.

Duality Advisers first reported a position in ZBH in Q4 2018 and held it in 7 quarters. The position peaked at $11.6M in Q4 2018. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

Duality Advisers reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
Duality Advisers sold 2,680 Zimmer Biomet shares in Q4 2023, an estimated $301K.
Duality Advisers first reported a position in Zimmer Biomet in Q4 2018 and held it in 7 quarters.
Duality Advisers's Zimmer Biomet position peaked at $11.6M in Q4 2018.
1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Duality Advisers's 13F filing for Q4 2023, filed 1 Feb 2024.